Oral Peptide Drug Market, Global Outlook and Forecast 2022-2028

April 2022 | 63 pages | ID: OF067A2006F7EN
Market Monitor Global

Abstracts

The drugs give through oral.

This report contains market size and forecasts of Oral Peptide Drug in Global, including the following market information:

Global Oral Peptide Drug Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global top five companies in 2021 (%)

The global Oral Peptide Drug market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period 2022-2028.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Linaclotide Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Oral Peptide Drug include Allergan, Novo Nordisk, Synergy Pharmaceuticals ?Salix?, Novartis and Chiasma, etc. In 2021, the global top five players have a share approximately % in terms of revenue.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Oral Peptide Drug companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Oral Peptide Drug Market, by Type, 2017-2022, 2023-2028 ($ millions)

Global Oral Peptide Drug Market Segment Percentages, by Type, 2021 (%)

• Linaclotide
• Insulin
• Plecanatide
• Cyclosporine
• Octreotide

Global Oral Peptide Drug Market, by Application, 2017-2022, 2023-2028 ($ millions)

Global Oral Peptide Drug Market Segment Percentages, by Application, 2021 (%)

• Hospital
• Retail Pharmacy

Global Oral Peptide Drug Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)

Global Oral Peptide Drug Market Segment Percentages, By Region and Country, 2021 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Oral Peptide Drug revenues in global market, 2017-2022 (estimated), ($ millions)

Key companies Oral Peptide Drug revenues share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

• Allergan
• Novo Nordisk
• Synergy Pharmaceuticals ?Salix?
• Novartis
• Chiasma

Contents

1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS

1.1 Oral Peptide Drug Market Definition
1.2 Market Segments
  1.2.1 Market by Type
  1.2.2 Market by Application
1.3 Global Oral Peptide Drug Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
  1.5.1 Research Methodology
  1.5.2 Research Process
  1.5.3 Base Year
  1.5.4 Report Assumptions & Caveats

2 GLOBAL ORAL PEPTIDE DRUG OVERALL MARKET SIZE

2.1 Global Oral Peptide Drug Market Size: 2021 VS 2028
2.2 Global Oral Peptide Drug Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
  2.3.1 Market Opportunities & Trends
  2.3.2 Market Drivers
  2.3.3 Market Restraints

3 COMPANY LANDSCAPE

3.1 Top Oral Peptide Drug Players in Global Market
3.2 Top Global Oral Peptide Drug Companies Ranked by Revenue
3.3 Global Oral Peptide Drug Revenue by Companies
3.4 Top 3 and Top 5 Oral Peptide Drug Companies in Global Market, by Revenue in 2021
3.5 Global Companies Oral Peptide Drug Product Type
3.6 Tier 1, Tier 2 and Tier 3 Oral Peptide Drug Players in Global Market
  3.6.1 List of Global Tier 1 Oral Peptide Drug Companies
  3.6.2 List of Global Tier 2 and Tier 3 Oral Peptide Drug Companies

4 MARKET SIGHTS BY PRODUCT

4.1 Overview
  4.1.1 by Type - Global Oral Peptide Drug Market Size Markets, 2021 & 2028
  4.1.2 Linaclotide
  4.1.3 Insulin
  4.1.4 Plecanatide
  4.1.5 Cyclosporine
  4.1.6 Octreotide
4.2 By Type - Global Oral Peptide Drug Revenue & Forecasts
  4.2.1 By Type - Global Oral Peptide Drug Revenue, 2017-2022
  4.2.2 By Type - Global Oral Peptide Drug Revenue, 2023-2028
  4.2.3 By Type - Global Oral Peptide Drug Revenue Market Share, 2017-2028

5 SIGHTS BY APPLICATION

5.1 Overview
  5.1.1 By Application - Global Oral Peptide Drug Market Size, 2021 & 2028
  5.1.2 Hospital
  5.1.3 Retail Pharmacy
5.2 By Application - Global Oral Peptide Drug Revenue & Forecasts
  5.2.1 By Application - Global Oral Peptide Drug Revenue, 2017-2022
  5.2.2 By Application - Global Oral Peptide Drug Revenue, 2023-2028
  5.2.3 By Application - Global Oral Peptide Drug Revenue Market Share, 2017-2028

6 SIGHTS BY REGION

6.1 By Region - Global Oral Peptide Drug Market Size, 2021 & 2028
6.2 By Region - Global Oral Peptide Drug Revenue & Forecasts
  6.2.1 By Region - Global Oral Peptide Drug Revenue, 2017-2022
  6.2.2 By Region - Global Oral Peptide Drug Revenue, 2023-2028
  6.2.3 By Region - Global Oral Peptide Drug Revenue Market Share, 2017-2028
6.3 North America
  6.3.1 By Country - North America Oral Peptide Drug Revenue, 2017-2028
  6.3.2 US Oral Peptide Drug Market Size, 2017-2028
  6.3.3 Canada Oral Peptide Drug Market Size, 2017-2028
  6.3.4 Mexico Oral Peptide Drug Market Size, 2017-2028
6.4 Europe
  6.4.1 By Country - Europe Oral Peptide Drug Revenue, 2017-2028
  6.4.2 Germany Oral Peptide Drug Market Size, 2017-2028
  6.4.3 France Oral Peptide Drug Market Size, 2017-2028
  6.4.4 U.K. Oral Peptide Drug Market Size, 2017-2028
  6.4.5 Italy Oral Peptide Drug Market Size, 2017-2028
  6.4.6 Russia Oral Peptide Drug Market Size, 2017-2028
  6.4.7 Nordic Countries Oral Peptide Drug Market Size, 2017-2028
  6.4.8 Benelux Oral Peptide Drug Market Size, 2017-2028
6.5 Asia
  6.5.1 By Region - Asia Oral Peptide Drug Revenue, 2017-2028
  6.5.2 China Oral Peptide Drug Market Size, 2017-2028
  6.5.3 Japan Oral Peptide Drug Market Size, 2017-2028
  6.5.4 South Korea Oral Peptide Drug Market Size, 2017-2028
  6.5.5 Southeast Asia Oral Peptide Drug Market Size, 2017-2028
  6.5.6 India Oral Peptide Drug Market Size, 2017-2028
6.6 South America
  6.6.1 By Country - South America Oral Peptide Drug Revenue, 2017-2028
  6.6.2 Brazil Oral Peptide Drug Market Size, 2017-2028
  6.6.3 Argentina Oral Peptide Drug Market Size, 2017-2028
6.7 Middle East & Africa
  6.7.1 By Country - Middle East & Africa Oral Peptide Drug Revenue, 2017-2028
  6.7.2 Turkey Oral Peptide Drug Market Size, 2017-2028
  6.7.3 Israel Oral Peptide Drug Market Size, 2017-2028
  6.7.4 Saudi Arabia Oral Peptide Drug Market Size, 2017-2028
  6.7.5 UAE Oral Peptide Drug Market Size, 2017-2028

7 PLAYERS PROFILES

7.1 Allergan
  7.1.1 Allergan Corporate Summary
  7.1.2 Allergan Business Overview
  7.1.3 Allergan Oral Peptide Drug Major Product Offerings
  7.1.4 Allergan Oral Peptide Drug Revenue in Global Market (2017-2022)
  7.1.5 Allergan Key News
7.2 Novo Nordisk
  7.2.1 Novo Nordisk Corporate Summary
  7.2.2 Novo Nordisk Business Overview
  7.2.3 Novo Nordisk Oral Peptide Drug Major Product Offerings
  7.2.4 Novo Nordisk Oral Peptide Drug Revenue in Global Market (2017-2022)
  7.2.5 Novo Nordisk Key News
7.3 Synergy Pharmaceuticals ?Salix?
  7.3.1 Synergy Pharmaceuticals ?Salix? Corporate Summary
  7.3.2 Synergy Pharmaceuticals ?Salix? Business Overview
  7.3.3 Synergy Pharmaceuticals ?Salix? Oral Peptide Drug Major Product Offerings
  7.3.4 Synergy Pharmaceuticals ?Salix? Oral Peptide Drug Revenue in Global Market (2017-2022)
  7.3.5 Synergy Pharmaceuticals ?Salix? Key News
7.4 Novartis
  7.4.1 Novartis Corporate Summary
  7.4.2 Novartis Business Overview
  7.4.3 Novartis Oral Peptide Drug Major Product Offerings
  7.4.4 Novartis Oral Peptide Drug Revenue in Global Market (2017-2022)
  7.4.5 Novartis Key News
7.5 Chiasma
  7.5.1 Chiasma Corporate Summary
  7.5.2 Chiasma Business Overview
  7.5.3 Chiasma Oral Peptide Drug Major Product Offerings
  7.5.4 Chiasma Oral Peptide Drug Revenue in Global Market (2017-2022)
  7.5.5 Chiasma Key News

8 CONCLUSION

9 APPENDIX

9.1 Note
9.2 Examples of Clients
9.3 Disclaimer

List Of Tables

LIST OF TABLES

Table 1. Oral Peptide Drug Market Opportunities & Trends in Global Market
Table 2. Oral Peptide Drug Market Drivers in Global Market
Table 3. Oral Peptide Drug Market Restraints in Global Market
Table 4. Key Players of Oral Peptide Drug in Global Market
Table 5. Top Oral Peptide Drug Players in Global Market, Ranking by Revenue (2021)
Table 6. Global Oral Peptide Drug Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global Oral Peptide Drug Revenue Share by Companies, 2017-2022
Table 8. Global Companies Oral Peptide Drug Product Type
Table 9. List of Global Tier 1 Oral Peptide Drug Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Oral Peptide Drug Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Oral Peptide Drug Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Oral Peptide Drug Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - Oral Peptide Drug Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application – Global Oral Peptide Drug Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - Oral Peptide Drug Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - Oral Peptide Drug Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region – Global Oral Peptide Drug Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global Oral Peptide Drug Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global Oral Peptide Drug Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America Oral Peptide Drug Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America Oral Peptide Drug Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe Oral Peptide Drug Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe Oral Peptide Drug Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia Oral Peptide Drug Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia Oral Peptide Drug Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America Oral Peptide Drug Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America Oral Peptide Drug Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa Oral Peptide Drug Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa Oral Peptide Drug Revenue, (US$, Mn), 2023-2028
Table 30. Allergan Corporate Summary
Table 31. Allergan Oral Peptide Drug Product Offerings
Table 32. Allergan Oral Peptide Drug Revenue (US$, Mn), (2017-2022)
Table 33. Novo Nordisk Corporate Summary
Table 34. Novo Nordisk Oral Peptide Drug Product Offerings
Table 35. Novo Nordisk Oral Peptide Drug Revenue (US$, Mn), (2017-2022)
Table 36. Synergy Pharmaceuticals ?Salix? Corporate Summary
Table 37. Synergy Pharmaceuticals ?Salix? Oral Peptide Drug Product Offerings
Table 38. Synergy Pharmaceuticals ?Salix? Oral Peptide Drug Revenue (US$, Mn), (2017-2022)
Table 39. Novartis Corporate Summary
Table 40. Novartis Oral Peptide Drug Product Offerings
Table 41. Novartis Oral Peptide Drug Revenue (US$, Mn), (2017-2022)
Table 42. Chiasma Corporate Summary
Table 43. Chiasma Oral Peptide Drug Product Offerings
Table 44. Chiasma Oral Peptide Drug Revenue (US$, Mn), (2017-2022)

List Of Figures

LIST OF FIGURES

Figure 1. Oral Peptide Drug Segment by Type in 2021
Figure 2. Oral Peptide Drug Segment by Application in 2021
Figure 3. Global Oral Peptide Drug Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Oral Peptide Drug Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Oral Peptide Drug Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Oral Peptide Drug Revenue in 2021
Figure 8. By Type - Global Oral Peptide Drug Revenue Market Share, 2017-2028
Figure 9. By Application - Global Oral Peptide Drug Revenue Market Share, 2017-2028
Figure 10. By Region - Global Oral Peptide Drug Revenue Market Share, 2017-2028
Figure 11. By Country - North America Oral Peptide Drug Revenue Market Share, 2017-2028
Figure 12. US Oral Peptide Drug Revenue, (US$, Mn), 2017-2028
Figure 13. Canada Oral Peptide Drug Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico Oral Peptide Drug Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe Oral Peptide Drug Revenue Market Share, 2017-2028
Figure 16. Germany Oral Peptide Drug Revenue, (US$, Mn), 2017-2028
Figure 17. France Oral Peptide Drug Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. Oral Peptide Drug Revenue, (US$, Mn), 2017-2028
Figure 19. Italy Oral Peptide Drug Revenue, (US$, Mn), 2017-2028
Figure 20. Russia Oral Peptide Drug Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries Oral Peptide Drug Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux Oral Peptide Drug Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia Oral Peptide Drug Revenue Market Share, 2017-2028
Figure 24. China Oral Peptide Drug Revenue, (US$, Mn), 2017-2028
Figure 25. Japan Oral Peptide Drug Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea Oral Peptide Drug Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia Oral Peptide Drug Revenue, (US$, Mn), 2017-2028
Figure 28. India Oral Peptide Drug Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America Oral Peptide Drug Revenue Market Share, 2017-2028
Figure 30. Brazil Oral Peptide Drug Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina Oral Peptide Drug Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa Oral Peptide Drug Revenue Market Share, 2017-2028
Figure 33. Turkey Oral Peptide Drug Revenue, (US$, Mn), 2017-2028
Figure 34. Israel Oral Peptide Drug Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia Oral Peptide Drug Revenue, (US$, Mn), 2017-2028
Figure 36. UAE Oral Peptide Drug Revenue, (US$, Mn), 2017-2028
Figure 37. Allergan Oral Peptide Drug Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. Novo Nordisk Oral Peptide Drug Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. Synergy Pharmaceuticals ?Salix? Oral Peptide Drug Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. Novartis Oral Peptide Drug Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 41. Chiasma Oral Peptide Drug Revenue Year Over Year Growth (US$, Mn) & (2017-2022)